Doctor Led Diagnosis and Treatment for SIBO/IMO

Adaptable to meet the specific needs of your patients

New homepage banner images with Dani (6)

The OMED Health Breath Analyzer is the only at-home UKCA marked medical device with performance comparable to in-clinic breath testing, offering patients a convenient, accessible, and cost-effective solution for Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO) diagnosis and treatment. 

How it Works

The OMED Health gut health solution combines:

A medical device for measuring breath hydrogen and methane anytime, anywhere
A connected mobile app to allow symptom, lifestyle, diet tracking and reporting
At-Home breath collect with SIBO/IMO diagnosis and instant results using glucose or lactulose substrates
Antimicrobial/antibiotic treatment, dietary intervention (low FODMAP diet) and recovery plans
All overseen by OMED Health Doctors

OMED HEALTH BREATH ANALYZER

Designed for at home use, the handheld OMED Health Breath Analyzer is a UKCA‑marked, sensor-based handheld medical device engineered to accurately detect hydrogen (H₂) and methane (CH₄) in exhaled breath down to parts‑per‑million levels. Designed to simplify established in-clinic hydrogen methane breath test (HMBT) protocols, it employs MOS sensors behind a diffusion membrane and moisture‑blocking mesh to minimize interference and ensure clinical-grade accuracy

The Breath Analyzer has been validated against standard HMBT in-clinic systems with comparable performance.

Clinical Pathway Integration

For busy clinicians, OMED Health can deliver a portable, non-invasive, and cost-efficient approach for diagnosing and treating carbohydrate fermentation disorders such as SIBO and IMO, validated in rigorous comparisons against in clinic/laboratory HMBT instruments and supported by remote monitoring, app‑facilitated data logging, and Doctor guidance. The OMED Health Breath Analyzer and accompanying App enables accessible longitudinal patient tracking and therapeutic oversight.

OMED Health offers a structured, evidence-based pathway that integrates seamlessly into clinical practice. Our modular approach allows you to select the components most relevant to your patients’ needs – whether that’s accurate SIBO diagnosis, personalized treatment protocols, FODMAP dietary support, or ongoing patient management.

OMED Health Plans and At-home breath tests

SIBO/IMO Diagnosis

78% of people with IBS actually have SIBO or IMO, conditions that can be diagnosed and treated.

SIBO is characterized by an abnormal increase in the number and/or type of bacteria in the small intestine, particularly those more commonly found in the colon. It disrupts normal digestion and absorption, leading to a range of gastrointestinal and systemic symptoms. Typically, the small intestine harbors fewer than 10³ colony-forming units (CFU) per mL; in SIBO, levels exceed 10⁵ CFU/mL, often with a predominance of colonic-type flora.

Symptoms are non-specific and may include: bloating, flatulence, abdominal discomfort, diarrhea or steatorrhea and malnutrition and weight loss in severe cases.

Gold-standard diagnosis involves jejunal aspirate and culture, though this is invasive. Non-invasive hydrogen and methane breath tests (using glucose or lactulose substrates) are widely used in clinical practice. A rise in hydrogen ≥20 ppm within 90 minutes or methane ≥10 ppm at any point is considered diagnostic under current British Society of Gastroenterologists guidelines.

The OMED Health App guides the patient through the process step by step including preparation ahead of the SIBO test and how to use the Breath Analyzer throughout the test. The OMED Health Doctor will assess what substrate (glucose or lactulose) is the most appropriate for the patient and following prescription it will be delivered directly to the patient’s home.

Treatment

For patients testing positive for IMO or SIBO, OMED Health offers a Doctor-led, evidence-based treatment pathway. Each patient is managed by an OMED Health Doctor.

Antimicrobial
An tailored 14-day antimicrobial regimen composed of plant-derived extracts, essential oils, and digestive enzymes – formulated to target methane-producing archaea in IMO and bacterial overgrowth in SIBO. These interventions are designed to support microbiota rebalance and enhance digestive function. Each treatment course includes a follow-up substrate breath test (glucose or lactulose) to assess therapeutic response. Further treatment is only recommended if clinically indicated. This stepwise approach ensures treatment is individualized and cost-efficient – patients pay only for the interventions required.

Antibiotic Therapy for Refractory Cases

In cases where antimicrobial treatments do not achieve full symptom resolution, targeted antibiotic therapy may be warranted. This is determined following a 1:1 consultation with an OMED Health Doctor, who will evaluate clinical progress and prescribe appropriate agents based on symptom profile and breath test data.

The antibiotic protocol includes the prescribed course and a follow-up breath test substrate to evaluate treatment efficacy. This option is reserved for patients with persistent or relapsing symptoms, and is employed judiciously to optimize clinical outcomes while minimizing unnecessary antibiotic exposure.

Low FODMAP Plan: Doctor-Supported Dietary Therapy

The low FODMAP diet is a well-established and may alleviate symptoms in individuals with IBS and functional gastrointestinal disorders. The low Fodmap protocol involves three structured phases – elimination, gradual reintroduction, and personalized maintenance – to identify and manage food-related symptom triggers.

OMED Health’s FODMAP Plan is delivered with guided, step-by-step instructions to ensure adherence and nutritional adequacy with dietary oversight provided by you.

Consultations with an OMED Health Doctor

OMED Health offers can offer a one-to-one, 45-minute video consultations with a qualified Doctor to support patients at any stage of their gut health management pathway – whether at initial assessment, mid-treatment, or seeking general clinical guidance. These consultations are designed to provide personalized, evidence-based support to help optimize therapeutic outcomes. Appointments are available on demand and can be scheduled at the patient’s convenience via the OMED Health App.